Biodexa Pharmaceuticals PLC Enters Letter Agreements
Ticker: BDRX · Form: 6-K · Filed: May 15, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, agreement, pharmaceuticals
TL;DR
Biodexa inked new deals on May 15th, watch this space.
AI Summary
On May 15, 2025, Biodexa Pharmaceuticals PLC entered into letter agreements with certain parties. The company, formerly known as Midatech Pharma Plc, is a pharmaceutical preparations company based in Cardiff, United Kingdom.
Why It Matters
This filing indicates new contractual developments for Biodexa Pharmaceuticals PLC, which could impact its ongoing operations and future strategies.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of letter agreements and does not contain significant financial or operational changes.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- May 15, 2025 (date) — Date of agreement
- Cardiff, United Kingdom (location) — Company headquarters
FAQ
What is the nature of the letter agreements entered into by Biodexa Pharmaceuticals PLC?
The filing states that on May 15, 2025, Biodexa Pharmaceuticals PLC entered into letter agreements with certain parties, but the specific details of these agreements are not provided in this excerpt.
When was Biodexa Pharmaceuticals PLC formerly known as?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals PLC headquartered?
Biodexa Pharmaceuticals PLC is headquartered at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
What is the Commission File Number for Biodexa Pharmaceuticals PLC?
The Commission File Number for Biodexa Pharmaceuticals PLC is 001-37652.
Does Biodexa Pharmaceuticals PLC file annual reports under Form 20-F or Form 40-F?
Biodexa Pharmaceuticals PLC files its annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).